Latest News

 Filter by Provider

The semiconductor industry, the bedrock of our digital age, is at a critical inflection point. Driven by the explosive growth of Artificial Intelligence (AI) and its insatiable demand for processing power, the industry is confronting its colossal environmental footprint head-on. Sustainable semiconductor manufacturing is no longer a niche concern but a central pillar for the [...]

The social media stock is falling. Here's why.

As of late 2025, the global landscape of artificial intelligence is increasingly defined not just by technological breakthroughs but by the intricate dance of international relations and national security interests. The geopolitical tug-of-war over advanced semiconductors, the literal building blocks of AI, has intensified, creating a "Silicon Curtain" that threatens to bifurcate global tech ecosystems. [...]

As the United States government grapples with a recent shutdown, which commenced on October 1, 2025, financial markets are witnessing a significant flight to safety, propelling gold and silver prices to unprecedented heights. The fiscal impasse, a stark reminder of political instability, has intensified an already anxious economic climate, driving

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.

The convergence of quantum computing and semiconductor technology is poised to redefine the landscape of artificial intelligence, promising to unlock computational capabilities previously unimaginable. This groundbreaking intersection is not merely an incremental upgrade but a fundamental shift, laying the groundwork for a new generation of intelligent systems that can tackle the world's most complex problems. [...]

As the global economy inches towards Q4 2025, the commodity market stands at a critical juncture, poised for a period of heightened volatility and diverging trends. While a broad softening of prices is anticipated across the board due to a projected global economic slowdown, specific commodity classes are charting markedly

In a pivotal shift for the semiconductor industry, advanced packaging technologies are rapidly emerging as the new frontier for enhancing artificial intelligence (AI) chip capabilities and efficiency. As the traditional scaling limits of Moore's Law become increasingly apparent, these innovative packaging solutions are providing a critical pathway to overcome bottlenecks in performance, power consumption, and [...]

A rival could be stealing the social media company's thunder in one hot corner of the tech space.

An oil tanker linked to Russian covert operations violated Western sanctions, according to French President Macron. The EU is investigating.

The global technology landscape is currently gripped by an unprecedented struggle for silicon supremacy: the AI chip wars. As of late 2025, this intense competition in the semiconductor market is not merely an industrial race but a geopolitical flashpoint, driven by the insatiable demand for artificial intelligence capabilities and escalating rivalries, particularly between the United [...]

The global agricultural commodity supply chain is navigating an unprecedented period of fragility, marked by a confluence of geopolitical instability, escalating climate change impacts, and persistent economic pressures. As of late 2025, these interconnected vulnerabilities are not merely theoretical risks but are actively disrupting the flow of essential food supplies,

Market strategist Jay Woods highlights two sectors that could see increased M&A activity in the fourth quarter and into 2026.

In the relentless pursuit of ever more powerful artificial intelligence, the spotlight often falls on groundbreaking algorithms, vast datasets, and innovative chip architectures. However, an often-overlooked yet critically foundational element is quietly undergoing a revolution: the supply of ultra-high purity (UHP) gases essential for semiconductor manufacturing. These advancements, driven by the imperative to fabricate next-generation [...]

The global industrial metals market in October 2025 finds itself at a pivotal juncture, characterized by a stark divergence in fortunes. While the relentless march towards a green energy future is igniting unprecedented demand for critical minerals essential for electric vehicles (EVs) and renewable energy, traditional industrial metals grapple with

PUMP (CRYPTO: PUMP) rose 12% on strong net inflows and breaking through key moving averages and Fibonacci levels. Momentum and inflow spike bode well for future gains. #PUMP #Uptober

Singapore, October 1, 2025 – In a significant move poised to bolster the global semiconductor supply chain, particularly for the burgeoning artificial intelligence (AI) chip sector, Air Liquide (a world leader in industrial gases) has announced a substantial investment of approximately 70 million euros (around $80 million) in Singapore. This strategic commitment, solidified through a [...]

Three stocks are lining up with powerful patterns that have played out with near-perfect reliability over the past decade.

In a bold strategic maneuver, Meta Platforms has accelerated its aggressive push into artificial intelligence (AI) by acquiring Rivos, a promising semiconductor startup specializing in custom chips for generative AI and data analytics. This pivotal acquisition, publicly confirmed by Meta's VP of Engineering on October 1, 2025, underscores the social media giant's urgent ambition to [...]

Cryptocurrencies surged on Wednesday, with Bitcoin convincingly surpassing the $117,000 mark.

Shares of fuel cell technology Plug Power (NASDAQ:PLUG) jumped 22.1% in the afternoon session after the company announced a significant project milestone: the delivery of its first 10-megawatt (MW) electrolyzer module to Galp's Sines Refinery in Portugal. This delivery marks the initial step in what is set to become one of Europe's largest proton exchange membrane (PEM) hydrogen electrolyzer projects. The module is the first of a 10-electrolyzer array that will create a total capacity of 100 MW. Once completed, the project will be capable of producing up to 15,000 tons of renewable hydrogen annually. This green hydrogen will replace 20% of the grey hydrogen currently used by the refinery, significantly reducing its greenhouse gas emissions. The news boosted investor confidence, highlighting Plug Power's progress in deploying its technology at scale and strengthening its position in the European green energy market.

Shares of solar tracking systems manufacturer Array (NASDAQ:ARRY) jumped 10.3% in the afternoon session after the stock's positive momentum continued as analysts at both Baird and Deutsche Bank initiated coverage on the stock with favorable ratings. Baird assigned an "Outperform" rating, while Deutsche Bank started its coverage with a "Buy" rating, with both firms setting a price target of $11. In its analysis, Baird noted that the solar tracker maker stands to benefit from U.S. policy clarity and rising utility-scale solar demand. Deutsche Bank referred to Array Technologies as a "turnaround story," citing the management's focus on high-quality customers and a growing backlog of orders. The positive analyst sentiment coincided with a broader rally in the clean energy sector, supported by favorable developments such as changes in the EU's electricity market to better integrate solar energy.

Shares of customer platform provider HubSpot (NYSE:HUBS) fell 7.2% in the afternoon session after OpenAI announced internal software applications that could potentially compete with existing Software-as-a-Service (SaaS) offerings. The news sparked concerns across the sector, as OpenAI revealed internally developed tools for sales, inbound marketing, and customer support—core areas for HubSpot. According to TD Cowen analyst Derrick Wood, the announcement has "re-fueled the debate that SaaS is at risk of being displaced by DIY solutions on top of LLMs." The potential for OpenAI to enter the applications market with its own AI-native solutions triggered a broader sell-off among enterprise software stocks. Despite the negative sentiment, Wells Fargo initiated coverage on HubSpot with an "Overweight" rating and a price target of $685, signaling confidence in the company's long-term prospects.

Shares of go-to-market intelligence provider ZoomInfo (NASDAQ:GTM) fell 4.4% in the afternoon session after Wells Fargo initiated coverage on the software company with an 'Underweight' rating. The bank and analyst Ryan Macwilliams set a price target of $10.00 for the stock. This new coverage was part of a broader initiation by Wells Fargo on 18 small and mid-cap software stocks, with the bank highlighting artificial intelligence as a major turning point for the sector. While several other companies received 'Equal Weight' ratings, ZoomInfo was singled out with the negative 'Underweight' assessment, indicating that the bank is less optimistic about its future performance compared to its peers.

Shares of bitcoin development company Strategy (NASDAQ:MSTR) jumped 4.5% in the afternoon session after the U.S. Treasury Department and IRS indicated the company may avoid the 15% U.S. corporate alternative minimum tax on its substantial unrealized cryptocurrency gains. The interim rule clarifies that companies can exclude unrealized gains and losses on digital assets, such as Bitcoin, when calculating their tax liability. This development is particularly significant for Strategy, the world's largest corporate Bitcoin holder, as it has previously flagged the risk of a multi-billion-dollar tax bill on its more than $27 billion in unrealized profits. The favorable guidance removes this major financial uncertainty for the company. The stock's rise also occurred as the price of Bitcoin surged, lifting other cryptocurrency-linked equities.

Shares of clinical research company IQVIA (NYSE: IQV) jumped 6.3% in the afternoon session after the company, in partnership with GSK, announced a major update to its Vaccine Track data tool for tracking adult immunization activity in the U.S. The enhancement adds local-level data for 387 metro areas and expands the dataset to a full decade of information. This update is designed to help public health organizations and providers identify immunization gaps and improve their community outreach efforts. The collaboration with pharmaceutical giant GSK underscores IQVIA's role in providing critical health data analytics. This development occurs within a positive industry context, as the broader biologics contract research organization market, a key sector for IQVIA, is projected to experience strong growth due to increased outsourcing of R&D by large pharmaceutical firms.

Shares of industrial products company CSW (NASDAQ:CSW) jumped 4.2% in the afternoon session after the company announced agreed to acquire Motors & Armatures Parts (MARS) for $650 million in a cash deal. The acquisition, which is CSW's largest to date, includes a potential $20 million earn-out based on future revenue targets. MARS is a leading North American distributor of parts for heating, ventilation, air conditioning, and refrigeration (HVAC/R), which will significantly expand CSW's product portfolio in that market. Investors reacted positively as the deal is expected to be immediately accretive to CSW's earnings. The company projects the acquired business will achieve an EBITDA margin of over 30% within 12 months of the transaction's closing, signaling a strong potential for accelerated growth and increased shareholder value.

Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) jumped 2.1% in the afternoon session after the company announced a specialty pharmacy partnership with Curant Health. Corcept has selected Curant Health's 'Curant Rare' division to provide personalized care and coordinated access to therapy for its patients. The partnership is designed to offer comprehensive support to patients and caregivers, helping them navigate the complexities of their treatment. This development comes as Corcept continues to rely on its sole-marketed drug, Korlym, for treating Cushing's syndrome. The company is also working to advance its lead pipeline candidate, relacorilant, for the same condition, aiming to broaden its patient base and reduce its dependence on a single product in the future.

Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 6.6% in the afternoon session after its subsidiary, Leica Biosystems, announced the launch of new artificial intelligence (AI)-powered digital pathology solutions. 

Shares of EV charging infrastructure provider Blink Charging (NASDAQ:BLNK) jumped 8.5% in the afternoon session after the company announced it has been awarded a contract by the City of Richmond to develop a network of electric vehicle (EV) charging stations. 

Shares of data center products and services company Vertiv (NYSE:VRT) jumped 6.8% in the afternoon session after Barclays raised its price target on the stock, citing strong demand for artificial intelligence (AI) infrastructure. 

Shares of health insurance company Humana (NYSE:HUM) fell 5.2% in the afternoon session after the company announced it will reduce the reach of its Medicare Advantage plans next year, citing rising costs. The health insurer will decrease its Medicare Advantage presence from 48 states to 46 and will cover 85% of U.S. counties, down from 89% this year. This decision comes as insurers face higher utilization of medical services and claim that government payments have not kept up with increasing costs. The pullback is not unique to Humana, as other major insurers are also retreating from less profitable markets. For instance, CVS Health's Aetna announced a similar reduction in its plan offerings. Despite the smaller footprint for its main Medicare Advantage plans, Humana did note that it expects to lower premiums for about 83% of its stand-alone prescription drug plans in the coming year.

Shares of semiconductor maker Penguin Solutions (NASDAQ:PENG) jumped 2.3% in the afternoon session after an analyst at Rosenblatt reiterated a "Buy" rating and significantly raised the price target on the stock. Rosenblatt analyst Kevin Cassidy increased the price target on Penguin Solutions to $36 from $27, representing a 33.33% jump in expected value. The firm anticipates the company will surpass consensus estimates and its own fiscal 2025 guidance. This optimism is reportedly driven by stronger-than-expected memory demand and pricing. Cassidy noted that Penguin Solutions, which is scheduled to report its fiscal fourth-quarter results on October 7, is likely to deliver a "modest beat" on expectations due to these favorable market conditions.

Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 5.2% in the afternoon session after the company submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) for its drug candidate pivekimab sunirine. The company is developing the molecule as a potential treatment for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and highly aggressive blood cancer, as well as acute myeloid leukemia (AML). Investor optimism was further bolstered by AbbVie's announcement of a $70 million expansion of its Bioresearch Center in Massachusetts to increase its U.S. biologics manufacturing and R&D capabilities. This move is part of a larger investment to strengthen domestic operations, potentially shielding the company from pharmaceutical tariffs. The positive news, which followed the stock reaching an all-time high on the previous day, appeared to outweigh a downgrade from HSBC to 'Hold' from 'Buy'.

The global energy market, as of October 1, 2025, is experiencing a period of profound rebalancing, characterized by a significant divergence in the outlooks for oil and natural gas. While crude oil prices face persistent downward pressure due to an anticipated oversupply and sluggish demand, the natural gas sector, particularly

Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 7.2% in the afternoon session after the company announced a landmark agreement with the U.S. government aimed at lowering prescription drug prices for American patients. 

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 8.6% in the afternoon session after the stock's positive momentum continued as the White House revealed plans to launch a website for consumers to purchase drugs from manufacturers at a discount, providing clarity for the pharmaceutical industry on future pricing policies. The positive sentiment was bolstered by news that competitor Pfizer had already secured a deal to lower some of its U.S. drug prices. Following this, Eli Lilly confirmed it is in "active discussions with the administration to further expand patient access." This development has eased investor concerns about potential government-imposed price controls, which had created uncertainty for the sector. The prospect of reaching favorable agreements is now seen as an opportunity for major drugmakers, leading to a rally across the industry.

Shares of electronic signature company DocuSign (NASDAQ:DOCU) fell 4.2% in the afternoon session after the stock continued to decline as ChatGPT developer OpenAI unveiled a new competing product, DocuGPT. 

Shares of electronic trading platform Tradeweb Markets (NASDAQ:TW) fell 3.8% in the afternoon session after Morgan Stanley lowered its price target on the stock to $125 from $149. Despite the significant 16% reduction in the price target, the investment firm, led by analyst Michael Cyprys, maintained its "Equal-Weight" rating on the shares. The adjustment was part of a broader update of price targets for companies in the Brokers & Exchanges North America sector. The negative sentiment surrounding Tradeweb also coincided with wider market weakness, as U.S. stocks declined following the failure of lawmakers to reach a funding deal, which triggered a government shutdown and clouded the economic outlook for investors.

Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 7.7% in the afternoon session after the Trump administration announced a new program to sell drugs directly to consumers. 

Shares of life sciences company Thermo Fisher (NYSE:TMO) jumped 9% in the afternoon session after the company secured a major manufacturing agreement with biotechnology firm Vaxcyte and announced a new AI-focused partnership. 

Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the afternoon session after the company announced the launch of BioInsight, a new business unit designed to accelerate drug discovery using artificial intelligence. The new venture aims to help researchers and pharmaceutical companies analyze and interpret vast amounts of complex biological data, known as multiomic data. By combining its strengths in genetic sequencing, software, and AI, Illumina's BioInsight unit will provide solutions to identify new drug targets, understand biological pathways, and uncover disease mechanisms. This strategic move is intended to meet growing industry demand for data-driven insights, supporting the company's long-term growth by expanding its role in the life sciences and healthcare sectors.

Shares of biotech company Amgen (NASDAQ:AMGN) jumped 6.4% in the afternoon session after the company announced a $650 million investment to expand its US manufacturing network. The investment is aimed at increasing drug production at its biologics facility in Juncos and is expected to create nearly 750 new jobs, including highly skilled manufacturing roles. According to CEO Robert A. Bradway, the expansion highlights Amgen's commitment to US biomanufacturing and strengthening its global supply chain. In other news, the company reached a settlement with Biocon Biologics. The agreement resolves pending patent litigation and allows Biocon to launch biosimilar versions of Amgen's drug, denosumab, in the U.S. starting October 1, 2025.

Shares of medical professional network Doximity (NYSE:DOCS) fell 3.2% in the afternoon session after Goldman Sachs downgraded the stock to Sell from a Neutral rating. The investment bank cited concerns over the company's high valuation and slowing growth, which it believes create an unfavorable risk/reward scenario for investors. Goldman Sachs set a price target of $64 for the stock.